Join the Pain group to help and get support from people like you.
Pain News (Page 4)
Vertex Advances VX-548 in Acute and Neuropathic Pain
VX-548 advances into pivotal development for people with acute pain; Phase 3 program to initiate in Q4 2022 Phase 2 dose-ranging trial in neuropathic pain expected to initiate by year end...
Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine
First published manuscript of VX-548 preclinical and clinical trial results in a peer-reviewed journal BOSTON--(BUSINESS WIRE)--Aug. 3, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX)...
Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain
BOSTON--Jan. 30, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from its Phase 3 program for the selective NaV1.8 inhibitor, VX-548, in the treatment of...
Pacira Announces FDA Approval of Expanded Exparel Label to Include Two Additional Nerve Block Indications
Exparel is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — New indications for use as an adductor c...
Caldolor Now FDA Approved for Treatment of Fever & Pain in Infants
NASHVILLE, Tenn., May 15, 2023 /PRNewswire/ – Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Medwatch Alert: Voluntary Recall of Certain Family Dollar Over-the-Counter Products
July 21, 2022 – Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently...
FDA Approves Seglentis (celecoxib and tramadol hydrochloride) for the Management of Acute Pain
October 18, 2021 – The U.S. Food and Drug Administration (FDA) approved Seglentis (celecoxib and tramadol hydrochloride), a proprietary product developed by Esteve Pharmaceuticals' R&D team. It is...
FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain
ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ – Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol h...
FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain
CHESTERBROOK, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) – Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
FDA Medwatch Alert: Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
May 20, 2020 – Biota Biosciences is voluntarily recalling the following lots in the table below of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables to the customer...
FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain
MALVERN, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) – Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug...
KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of Apadaz (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)
CORALVILLE, Iowa, Jan. 07, 2019 (GLOBE NEWSWIRE) – KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today...
FDA Medwatch Alert: Implanted Pumps: Safety Communication - Use Caution When Selecting Pain Medicine for Intrathecal Administration
ISSUE: The FDA is aware that patients undergoing treatment or management of pain are commonly given pain medicines in the spinal fluid (intrathecal administration) that are not FDA approved for use...
FDA Approves Dsuvia (sufentanil) Sublingual Tablets for Severe Pain
REDWOOD CITY, Calif., Nov. 2, 2018 /PRNewswire/ – AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...
Pacira Announces FDA Approval of Exparel as a Nerve Block to Produce Regional Analgesia
PARSIPPANY, N.J., April 06, 2018 (GLOBE NEWSWIRE) – Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug...
Further information
Related condition support groups
Chronic Pain, Back Pain, Fibromyalgia, Headache, Muscle Pain, Neuralgia, Neck Pain, Chronic Myofascial Pain, Reflex Sympathetic Dystrophy Syndrome, Nocturnal Leg Cramps, Breakthrough Pain
Related drug support groups
tramadol, gabapentin, oxycodone, ibuprofen, Tylenol, hydrocodone, naproxen, acetaminophen, meloxicam, view more... amitriptyline, aspirin, Percocet, hydroxyzine, Norco, duloxetine, pregabalin, diclofenac, methadone, codeine, cyclobenzaprine, OxyContin, Vicodin, Celebrex, Aleve, fentanyl, Advil, Voltaren, morphine, clonidine, buprenorphine, Paracetamol Teva, nortriptyline, Paracetamol, Butrans, cannabis, Motrin, Tylenol PM, Dilaudid, indomethacin, Toradol, Ultram, Lortab, Vistaril, acetaminophen / hydrocodone, ketamine, Roxicodone, Arthritis Pain, ketorolac, Atarax, Percocet 10/325, hydromorphone, Nucynta, Belbuca